| 0 (0%) | 11-11 17:41 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 52.55 | 1-year : | 61.39 |
| Resists | First : | 45 | Second : | 52.55 |
| Pivot price | 44.34  |
|||
| Supports | First : | 43.99 | Second : | 43.36 |
| MAs | MA(5) : | 44.7 |
MA(20) : | 44.25 |
| MA(100) : | 42.35 |
MA(250) : | 33.82 |
|
| MACD | MACD : | 0.2 |
Signal : | 0.1 |
| %K %D | K(14,3) : | 93.8 |
D(3) : | 86 |
| RSI | RSI(14): 69.1 | |||
| 52-week | High : | 45.29 | Low : | 18.37 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ USAP ] has closed below upper band by 8.4%. Bollinger Bands are 56.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 54 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 45.04 - 45.28 | 45.28 - 45.48 |
| Low: | 44.41 - 44.69 | 44.69 - 44.92 |
| Close: | 44.54 - 45.01 | 45.01 - 45.4 |
Mon, 27 Oct 2025
U.S. Anesthesia Partners Teams with Nova Southeastern University to Help Address Serious Anesthesia Clinician Shortage - NSU Newsroom
Sat, 25 Oct 2025
Care Week Takes U.S. Anesthesia Partners to Genesis - People Newspapers
Wed, 27 Aug 2025
ANTITRUST—S.D. Tex.: Welsh Carson dismissed, USAP will defend yet another anesthesiology antitrust action - VitalLaw.com
Tue, 22 Jul 2025
The Universal Security Audit Programme Continuous Monitoring Approach (USAP-CMA) and its Objective - International Civil Aviation Organization
Tue, 10 Jun 2025
US Anesthesia Partners Names Dr. Kurt Jones Chief Clinical Officer - citybiz
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 9 (M) |
| Shares Float | 9 (M) |
| Held by Insiders | 6.6 (%) |
| Held by Institutions | 77 (%) |
| Shares Short | 433 (K) |
| Shares Short P.Month | 295 (K) |
| EPS | 2.73 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 27.2 |
| Profit Margin | 8.1 % |
| Operating Margin | 15.6 % |
| Return on Assets (ttm) | 6.6 % |
| Return on Equity (ttm) | 11.1 % |
| Qtrly Rev. Growth | 22.3 % |
| Gross Profit (p.s.) | 7.51 |
| Sales Per Share | 34.75 |
| EBITDA (p.s.) | 6.27 |
| Qtrly Earnings Growth | 455 % |
| Operating Cash Flow | 37 (M) |
| Levered Free Cash Flow | 12 (M) |
| PE Ratio | 16.47 |
| PEG Ratio | 0 |
| Price to Book value | 1.65 |
| Price to Sales | 1.29 |
| Price to Cash Flow | 11.51 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|